BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+7.76%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$572M
AUM Growth
+$572M
(-1.7%)
Cap. Flow
-$6.13M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
86.44%
Holding
30
New
4
Increased
5
Reduced
6
Closed
4
Top Buys
| 1 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$20.6M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$19.5M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$7.74M |
| 5 |
Xencor
XNCR
|
$7.5M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$27.7M |
| 2 |
Exelixis
EXEL
|
$14.6M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$10.9M |
| 4 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$10.3M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$6.84M |
Sector Composition
| 1 | Healthcare | 76.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cassava Sciences
SAVA
$110M
| – | – | -2,357,327 | Closed | -$6.41M |
|
|
AVNR
27
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| – | – | -2,436,053 | Closed | -$10.3M |
|
|
GNVC
28
DELISTED
GenVec, Inc.
GNVC
| – | – | -486,100 | Closed | -$617K |
|